Papers about tirzepatide

Every paper here, unless its row says otherwiseIndexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

• Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity.

  JAMA network open2025PMID 40663350Indexed under tirzepatide in PubMed's chemical list

• Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: a multi-institutional propensity score-matched study.

  Hepatology international2025PMID 40668509

• Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1.

  Diabetes, obesity & metabolism2025PMID 40677091

• Exploring the Efficacy and Safety of Tirzepatide in Obesity Management and Cardiometabolic Risk Factors: A Comprehensive Systematic Review and Meta-Analysis.

  Clinical obesity2025PMID 40685889Also indexed under tirzepatide as a PubMed major topic

• Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.

  Diabetologia2025PMID 40694059

• Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.

  Diabetes care2025PMID 40694530

• Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial.

  Journal of the American College of Cardiology2025PMID 40701669

• Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials.

  Obesity (Silver Spring, Md.)2025PMID 40717199

• Weight Loss Efficacy of Tirzepatide Compared to Placebo or GLP-1 Receptor Agonists in Adults With Obesity or Overweight: A Meta-Analysis of Randomized Controlled Trials With ≥ 20 Weeks Treatment Duration.

  Journal of obesity2025PMID 40746703Also indexed under tirzepatide as a PubMed major topic; tests tirzepatide

• Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.

  Frontiers in endocrinology2025PMID 40747302Also indexed under tirzepatide as a PubMed major topic; tests tirzepatide

• Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic.

  Diabetes, obesity & metabolism2025PMID 40762026Indexed under tirzepatide in PubMed

• Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity.

  Sleep medicine2025PMID 40774158

• Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes.

  JAMA network open2025PMID 40788646Indexed under tirzepatide in PubMed's chemical list

• Beyond Weight Loss: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic Steatosis and Stiffness in MASLD.

  Nutrients2025PMID 40805994

• Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study.

  JMIR formative research2025PMID 40838489Indexed under tirzepatide in PubMed

• Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.

  Nature medicine2025PMID 40858971Also indexed under tirzepatide as a PubMed major topic

• Real-World Weight Loss Observed With Semaglutide and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE).

  Advances in therapy2025PMID 40875186Indexed under tirzepatide in PubMed

• Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.

  JAMA2025PMID 40886075Indexed under tirzepatide in PubMed

• Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis.

  Journal of the American College of Cardiology2025PMID 40903131Also indexed under tirzepatide as a PubMed major topic

• Tirzepatide Associated With Improved Health-Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT-4.

  Obesity (Silver Spring, Md.)2025PMID 40903801

• Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4.

  Diabetes, obesity & metabolism2025PMID 40926359Indexed under tirzepatide in PubMed's chemical list

• Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.

  Diabetes, obesity & metabolism2025PMID 40954943Also indexed under tirzepatide as a PubMed major topic

• Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide.

  Frontiers in endocrinology2025PMID 40964167Also indexed under tirzepatide as a PubMed major topic

• Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial.

  Lancet (London, England)2025PMID 40975112Also indexed under tirzepatide as a PubMed major topic

• Effects of tirzepatide on weight management in patients with and without diabetes: a systematic review and meta-analysis.

  International journal of obesity (2005)2025PMID 41015578Also indexed under tirzepatide as a PubMed major topic

• Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trial.

  Diabetes, obesity & metabolism2025PMID 41017451

• Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction- Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide.

  Diabetes care2025PMID 41066427

• Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.

  Journal of diabetes and its complications2025PMID 41075711Also indexed under tirzepatide as a PubMed major topic

• Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus.

  Endocrinology and metabolism (Seoul, Korea)2025PMID 41088952Indexed under tirzepatide in PubMed's chemical list

• Effect of Tirzepatide on Heart Failure in Type 2 Diabetes Mellitus and Obesity: A Systematic Review and Meta-Analysis.

  Diabetes/metabolism research and reviews2025PMID 41100405Also indexed under tirzepatide as a PubMed major topic

• Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight.

  Sleep medicine2025PMID 41135142

• Tirzepatide for adults living with obesity.

  The Cochrane database of systematic reviews2025PMID 41161687Also indexed under tirzepatide as a PubMed major topic; tests tirzepatide

• Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial.

  The lancet. Diabetes & endocrinology2025PMID 41167231Also indexed under tirzepatide as a PubMed major topic

• Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: A retrospective cohort study using the TriNetX database.

  Diabetes research and clinical practice2025PMID 41218687Also indexed under tirzepatide as a PubMed major topic

• Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-analysis.

  Obesity surgery2025PMID 41313431Indexed under tirzepatide in PubMed

• Effect of Tirzepatide on arrhythmic, major cardiovascular, and neurological outcomes in patients with type 2 diabetes: A systematic review and meta-analysis.

  Neurological sciences2025PMID 41402646Also indexed under tirzepatide as a PubMed major topic

• Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.

  The New England journal of medicine2025PMID 41406444Also indexed under tirzepatide as a PubMed major topic

• Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J-mono study.

  Diabetes, obesity & metabolism2024PMID 37794628

• Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.

  Diabetes, obesity & metabolism2024PMID 37828829

• Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.

  Diabetes, obesity & metabolism2024PMID 37853960

• Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis.

  Diabetes, obesity & metabolism2024PMID 37860884

• 5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.

  Diabetes, obesity & metabolism2024PMID 37867175Indexed under tirzepatide in PubMed's chemical list

• Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.

  Diabetes, obesity & metabolism2024PMID 37932236

• Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis.

  Pharmacological research2024PMID 38061595Indexed under tirzepatide in PubMed's chemical list

• Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.

  JAMA2024PMID 38078870

• Effect of tirzepatide on albuminuria levels and renal function in patients with type 2 diabetes mellitus: A systematic review and multilevel meta-analysis.

  Diabetes, obesity & metabolism2024PMID 38116693

• Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).

  The Journal of clinical endocrinology and metabolism2024PMID 38252888

• Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials.

  Frontiers in public health2024PMID 38356942

• Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis.

  European stroke journal2024PMID 38400569

• Efficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis.

  Obesity (Silver Spring, Md.)2024PMID 38413012